Citation Impact
Citing Papers
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
The gut microbiota and host health: a new clinical frontier
2015 Standout
Cell Type–Dependent Pro- and Anti-Inflammatory Role of Signal Transducer and Activator of Transcription 3 in Alcoholic Liver Injury
2008
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Hepatocellular carcinoma
2003 Standout
Limitations of non-invasive tests for assessment of liver fibrosis
2020
A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice
2008
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Hepatocellular carcinoma
2018 Standout
Genetic modifiers of non-alcoholic fatty liver disease progression
2011
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Mechanisms of liver fibrosis
2005
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Mining the Human Gut Microbiota for Immunomodulatory Organisms
2017
Cytochrome P450 3A
1999
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
2012
Hallmarks of aging: An expanding universe
2023 Standout
Use of thiopurines in inflammatory bowel disease: Safety issues
2014
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension
2004
Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?
2016
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Toll-Like Receptor 4 Mediates Alcohol-Induced Steatohepatitis Through Bone Marrow-Derived and Endogenous Liver Cells in Mice
2011
Hepatobiliary surgery
2000
Analgesics in Patients with Hepatic Impairment
2012
Intestinal microbiota and nonalcoholic steatohepatitis
2017
Methods to determine intestinal permeability and bacterial translocation during liver disease
2015
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
2013 Standout
Pathological bacterial translocation in liver cirrhosis
2013
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Metazoan MicroRNAs
2018 Standout
Precision-Cut Liver Slices as a New Model to Study Toxicity-Induced Hepatic Stellate Cell Activation in a Physiologic Milieu
2005
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Gut–Liver Axis in Alcoholic Liver Disease
2014
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
Hepatitis C Virus Infection in Pregnancy
2020
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (Flirt 2) Extension Trial
2009
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
2011
Liver regeneration
2007
Self-consumption: the interplay of autophagy and apoptosis
2014 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis
2010
Current understanding of the human microbiome
2018 Standout
Benefit of Initial Resection of Hepatocellular Carcinoma Followed by Transplantation in Case of Recurrence
2011
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
Pulmonary–Hepatic vascular Disorders (PHD)
2004
The gut microbiota influences anticancer immunosurveillance and general health
2018
Animal models of nonalcoholic fatty liver disease
2010
Transcriptional regulation of stellate cell activation
2006
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Characterization of fecal microbial communities in patients with liver cirrhosis
2011
Induced pluripotent stem cell–derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice
2010 StandoutNobel
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense
2011
Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats
2015
Infection in Solid-Organ Transplant Recipients
2007 Standout
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results
2003
Ethanol metabolism and its effects on the intestinal epithelial barrier
2013
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
2012
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
The human microbiome: at the interface of health and disease
2012 Standout
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
2020 Standout
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
Microbial Translocation in Chronic Liver Diseases
2012
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
2018 StandoutScience
Ras inhibition enhances autophagy, which partially protects cells from death
2013
Fast Hepatitis C Virus RNA Elimination and NS5A Redistribution by NS5A Inhibitors Studied by a Multiplex Assay Approach
2015 StandoutNobel
Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
2013
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature
2013
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk
2015
Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease
2016
Alcohol and Gut-Derived Inflammation
2017
Gut Microbiota and Host Reaction in Liver Diseases
2015
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Works of Peter Stärkel being referenced
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
2015
Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity
2014
Outcome of liver transplantation for patients with pulmonary hypertension
2002
Outcome of Patients With Hepatocellular Carcinoma Listed for Liver Transplantation Within the Eurotransplant Allocation System
2008
Animal models for the study of hepatic fibrosis
2011
Expression and DNA-Binding Activity of Signal Transducer and Activator of Transcription 3 in Alcoholic Cirrhosis Compared to Normal Liver and Primary Biliary Cirrhosis in Humans
2003
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis
2018
Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation
2016
Defective hepatic regeneration after partial hepatectomy in leptin-deficient mice is not rescued by exogenous leptin
2006
Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARγ agonist pioglitazone
2006
Enteric dysbiosis associated with a mouse model of alcoholic liver disease
2010
Alfentanil-Induced Miosis as a Surrogate Measure of Alfentanil Pharmacokinetics in Patients with Mild and Moderate Liver Cirrhosis
2007
Supplementation of Saturated Long-Chain Fatty Acids Maintains Intestinal Eubiosis and Reduces Ethanol-induced Liver Injury in Mice
2014
Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice
2013
After Portal Branch Ligation in Rat, Nuclear Factor κB, Interleukin–6, Signal Transducers and Activators of Transcription 3, C– Fos , C– Myc , and C– Jun Are Similarly Induced in the Ligated and Nonligated Lobes
1999
Thiopurine metabolism monitoring: implications in inflammatory bowel diseases
2010
Role of Inflammatory Pathways, Blood Mononuclear Cells, and Gut-Derived Bacterial Products in Alcohol Dependence
2014
Oxidative stress, KLF6 and transforming growth factor-β up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats
2003
Favorable outcome of orthotopic liver transplantation in a patient with subacute liver failure due to the emergence of a hepatitis B YMDD escape mutant virus
2001
CYP 3A proteins are expressed in human neutrophils and lymphocytes but are not induced by rifampicin
1999
Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition
2010
Cytochrome P450 3A proteins are expressed in B lymphocytes but not in T lymphocytes.
1999
Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosis
2005
Current and future health and economic impact of hepatitis C in Belgium.
2014
Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice
2014
Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.
2012
Peroxisome proliferated-activated receptor γ ligand, Pioglitazone, does not prevent hepatic fibrosis in mice
2007